Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Merck Sharp & Dohme LLC
Alpha-9 Oncology USA Inc.
Fred Hutchinson Cancer Center
Mayo Clinic
BioNTech SE
Aminex Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Massachusetts General Hospital
Canadian Cancer Trials Group
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of California, Irvine
Toray Industries, Inc
Merck Sharp & Dohme LLC
Ankyra Therapeutics, Inc
Dren Bio
STORM Therapeutics LTD
University Health Network, Toronto
Pfizer
European Organisation for Research and Treatment of Cancer - EORTC
University of Southern California
Boehringer Ingelheim
Hanmi Pharmaceutical Company Limited
Thomas Jefferson University
Psyence Australia Pty Ltd
Merck Sharp & Dohme LLC
Suzhou BlueHorse Therapeutics Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
MonTa Biosciences ApS
Eastern Cooperative Oncology Group
Aura Biosciences
Neonc Technologies, Inc.
ViroMissile, Inc.
Hummingbird Bioscience
University of Wisconsin, Madison
Replimune Inc.
University of Pittsburgh
Ipsen
University of Cincinnati
Bristol-Myers Squibb
Dana-Farber Cancer Institute